Real-world predictors of 12–month intravenous abatacept retention in patients with rheumatoid arthritis in the ACTION observational study | RMD Open
Novel therapeutic targets in rheumatoid arthritis: Trends in Pharmacological Sciences
PPT - Abatacept (hCTLA4-Ig) For the Treatment of Rheumatoid Arthritis: PowerPoint Presentation - ID:286368
Abatacept Targets T Follicular Helper and Regulatory T Cells, Disrupting Molecular Pathways That Regulate Their Proliferation and Maintenance | The Journal of Immunology
Abatacept in Steroid-Dependent Minimal Change Disease and CD80-uria - Kidney International Reports
PPT – Abatacept (ORENCIA) for Rheumatoid Arthritis PowerPoint presentation | free to view - id: dd71d-ZDc1Z
Costimulation blockade in autoimmunity and transplantation - Journal of Allergy and Clinical Immunology
Pharmacological Management of Rheumatoid Arthritis - Physiopedia
CD4+ T cells cause renal and placental mitochondrial oxidative stress as mechanisms of hypertension in response to placental ischemia | American Journal of Physiology-Renal Physiology
PPT – Abatacept PowerPoint presentation | free to view - id: 149321-ODVjN
Abatacept - Renal Fellow Network
illustration describing the mechanism of action of abatacept. Abatacept... | Download Scientific Diagram
Treat to Target, Role of Orencia in Achieving the target. - ppt download
Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers | Nature Reviews Rheumatology
Cytokines And Biologic Treatment in Arthritis - ppt download
Biologics in Rheumatology - презентация онлайн
Abatacept in IgG4-related disease: a prospective, open-label, single-arm, single-centre, proof-of-concept study - The Lancet Rheumatology
Biologics in Rheumatology - презентация онлайн
Abatacept, a Novel CD80/86–CD28 T Cell Co‐stimulation Modulator, in the Treatment of Rheumatoid Arthritis - Korhonen - 2009 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library
Abatacept (hCTLA4-Ig) For the Treatment of Rheumatoid Arthritis: Product Attributes and Mechanism of Action Joy Williams, Ph.D. Arthritis Advisory Committee. - ppt download
References in Are calcineurin inhibitors-free regimens ready for prime time? - Kidney International
Cost-Effectiveness Analysis of Abatacept Compared with Adalimumab on Background Methotrexate in Biologic-Naive Adult Patients with Rheumatoid Arthritis and Poor Prognosis - Value in Health
Potential of regulatory T-cell-based therapies in the management of severe COVID-19 | European Respiratory Society
PDF) Up to 5-year retention of abatacept in Belgian patients with moderate-to-severe rheumatoid arthritis: a sub-analysis of the international, observational ACTION study
